There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edwards Lifesciences (EW – Research Report) and Dr Reddy's Laboratories (RDY – Research Report) with bullish sentiments. Edwards Lifesciences (EW) Barclays analyst Matt Miksic maintained a Buy rating on Edwards Lifesciences on October 28 and set a price target of $94.00. The company's shares closed last Friday at $70.87, close to its 52-week low of $69.70. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-and-dr-reddys-laboratories-rdy?utm_source=advfn.com&utm_medium=referral
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more Dr Reddys Laboratories Charts.
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more Dr Reddys Laboratories Charts.